• About
  • Partnerships
  • Challenges
  • Awarded Grants
  • Grant Opportunities
  • News

Strip Test for Glycated Albumin Screening

The proposed Rapid Strip Assay (RDT) for Glycated Albumin (GA) will allow us to determine with good sensitivity and moderate specificity if a pregnant woman is likely to develop diabetes. Combining biometric information and health history with the RDT result will improve specificity. The screening result can be used to counsel high-risk women on diet and exercise and additional care during delivery, or to provide them a follow-up OGCT and insulin. With the RDT for the new biomarker, health care systems can avoid the cost and inconvenience of having every pregnant woman go through an OGCT and can increase patient catchment for diabetes screening.

More information about Saving Lives at Birth (Round 2)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.